- Advertisement -

FDA-approved drug for chronic kidney disease may help mitigate antibiotic resistance

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial...

Bayer, Novartis, and Trump convicted by Nature – European Biotechnology

The politically overhyped use of old malaria drugs in combination with COVID-19-specific candidates has been demonstrated to be dangerous, reports Nature Medicine. In the prestigous...

China, Public Health, International Relations And Biotechnology – Analysis – Eurasia Review

The announcement by Dr. He Jiankui on YouTube that he used CRISPR-Cas9, a gene-editing technology, to edit the genes of twins was a timely...

Cytiva Introduces FlexFactory to Poland

SyVento Biotech, a CDMO, opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva, spanning over 7,000 m2, including lab and production areas,...

New antibody found to be highly protective against wide range of...

The virus that causes COVID-19 today is not the same as the one that first sickened people way back in December 2019. Many of...

Whole-Exome Sequencing Predicts Response to Cancer Immunotherapy

Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced stage cancers. Unlike chemotherapies that kill cancer cells, these drugs help the...

Using AI Agents and Bio-Foundation Models to Automate Vector Design for...

Register Now Panelists: Jamie Freeman, PhD VP of Business Development and Commercial StrategyAsimov...

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Using AI Agents and Bio-Foundation Models to Automate Vector Design for Cell Line Development

Register Now Panelists: Jamie Freeman, PhD VP of Business Development and Commercial StrategyAsimov...

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

more new items

Using AI Agents and Bio-Foundation Models to Automate Vector Design for...

Register Now Panelists: Jamie Freeman, PhD VP of Business Development and Commercial StrategyAsimov...

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...